The present invention relates generally to tissue fastening and, more particularly, tissue fastening performed in a minimally invasive and percutaneous manner.
Referring initially to
Mitral valve 20, which will be described below in more detail, includes an anterior leaflet 22 and a posterior leaflet 24 that are coupled to cordae tendonae 26, 28 (
Anterior leaflet 22 and posterior leaflet 24 of the mitral valve 20 are generally thin, flexible membranes. When mitral valve 20 is closed, anterior leaflet 22 and posterior leaflet 24 are generally aligned and contact one another along a “line of coaptation” several millimeters back from their free edges, to create a seal that prevents mitral regurgitation. Alternatively, when mitral valve 20 is opened, blood flows downwardly through an opening created between anterior leaflet 22 and posterior leaflet 24 into left ventricle 14.
Many problems relating to the mitral valve may occur and may cause many types of ailments. Such problems include, but are not limited to, mitral regurgitation. Mitral regurgitation, or leakage, is the backflow of blood from left ventricle 14 into the left atrium 12 due to an imperfect closure of mitral valve 20. That is, leakage often occurs when the anterior and posterior leaflets 22, 24 do not seal against each other, resulting in a gap between anterior leaflet 22 and posterior leaflet 24 when the leaflets are supposed to be fully coapted during systole.
In general, a relatively significant systolic gap may exist between anterior leaflet 22 and posterior leaflet 24 for a variety of different reasons. For example, a gap may exist due to congenital malformations, because of ischemic disease, or because the heart 10 has been damaged by a previous heart attack. Such a gap may also be created when congestive heart failure, e.g., cardiomyopathy, or some other type of distress which causes a heart 10 to be enlarged. Enlargement of the heart 10 can result in dilation (stretching) of the mitral annulus. This enlargement is usually limited to the posterior valve annulus and is associated with the posterior leaflet 24, because the anterior annulus is a relatively rigid fibrous structure. When the posterior annulus enlarges, it causes the posterior leaflet 24 to move away from the anterior leaflet 22, causing a gap during systole because the two leaflets no longer form proper coaptation. This results in leakage of blood through the valve 20, or regurgitation.
Blood leakage through mitral valve 20 generally causes a heart 10 to operate less efficiently, as the heart 10 pumps blood both out to the body via the aorta 16, and also back (in the form of mitral regurgitation) into the left atrium 12. Leakage through mitral valve 20, or general mitral insufficiency, is thus often considered to be a precursor to congestive heart failure (CHF) or a cause of progressive worsening of heart failure. There are generally different levels of symptoms associated with heart failure. These levels are classified by the New York Heart Association (NYHA) functional classification system. The levels range from a Class 1 level which is associated with an asymptomatic patient who has substantially no physical limitations to a Class 4 level which is associated with a patient who is unable to carry out any physical activity without discomfort and has symptoms of cardiac insufficiency even at rest. In general, correcting or reducing the degree of mitral valve leakage may be successful in allowing the NYHA classification grade of a patient to be reduced. For instance, a patient with a Class 4 classification may have his classification reduced to Class 3 or Class 2 and, hence, be relatively comfortable at rest or even during mild physical exertion. By eliminating the flow of blood backwards into the left atrium 12, therapies that reduce mitral insufficiency reduce the workload of the heart 10 and may prevent or slow the degradation of heart function and congestive heart failure symptoms that is common when a significant degree of mitral insufficiency remains uncorrected.
Treatments used to correct for mitral valve leakage or, more generally, CHF, are typically highly invasive, open-heart surgical procedures. In extreme cases, this may include implantation of a ventricular assist device such as an artificial heart in a patient with a failing heart. The implantation of a ventricular assist device is often expensive, and a patient with a ventricular assist device must be placed on extended anti-coagulant therapy. Anti-coagulant therapy reduces the risk of blood clot formation for example, within the ventricular assist device. Reducing the risks of blood clots associated with the ventricular assist device is desirable, but anti-coagulant therapies may increase the risk of uncontrollable bleeding in a patient, e.g., as a result of a fall.
Rather than implanting a ventricular assist device, bi-ventricular pacing devices similar to pacemakers may be implanted in some cases, e.g., cases in which a heart beats inefficiently in a particular asynchronous manner. While the implantation of a bi-ventricular pacing device may be effective, not all heart patients are suitable for receiving a bi-ventricular pacing device. Further, the implantation of a bi-ventricular pacing device is expensive, and is generally not effective in significantly reducing or eliminating the degree of mitral regurgitation.
Open-heart surgical procedures that are intended to correct for mitral valve leakage, specifically, can involve the implantation of a replacement valve. Valves from animals, e.g., pigs, may be used to replace a mitral valve 20 in a human. While a pig valve may relatively successfully replace a mitral valve, such replacement valves generally wear out, thereby requiring additional open surgery at a later date. Mechanical valves, which are less likely to wear out, may also be used to replace a leaking mitral valve. However, when a mechanical valve is implanted, there is an increased risk of thromboembolism, and a patient is generally required to undergo extended anti-coagulant therapies.
A less invasive surgical procedure involves heart bypass surgery associated with a port access procedure. For a port access procedure, the heart may be accessed by cutting between ribs or sometimes removing parts of one or more ribs, as opposed to dividing the sternum to open the entire chest of a patient.
One open-heart surgical procedure that is particularly successful in correcting for mitral valve leakage and, in addition, mitral regurgitation, is an annuloplasty procedure. During an annuloplasty procedure, a medical device such as an annuloplasty ring may be implanted surgically on the left atrial side of mitral annulus (i.e., generally the attachment location of the base of the mitral valve to the heart). The device reduces a dilated mitral valve annulus to a relatively normal size and, specifically, moves the posterior leaflet closer to the anterior leaflet to aid anterior—posterior leaflet coaptation and thus improve the quality of mitral valve closure during systole. Annuloplasty rings are often shaped substantially like the letter “D” to correspond to the natural shape of the mitral annulus as viewed from above. Typically, the rings are formed from a rod or tube of biocompatible material, e.g., plastic, that has a DACRON mesh covering.
In order for an annuloplasty ring to be implanted, a surgeon surgically attaches the annuloplasty ring to the mitral valve on the atrial side of the mitral valve. Conventional methods for installing a ring require open-heart surgery which involves opening a patient's sternum and placing the patient on a heart bypass machine. The annuloplasty ring is sewn on a top portion of the mitral valve. In sewing the annuloplasty ring onto the mitral valve, a surgeon generally sews the straight side of the “D” to the fibrous tissue located at the junction between the posterior wall of the aorta and the base of the anterior mitral valve leaflet. As the curved part of the ring is sewn to the posterior aspect of the annulus, the surgeon alternately acquires a relatively larger amount of tissue from the mitral annulus, e.g., a one-eighth inch bite of tissue, using a needle and thread, compared to a relatively smaller bite taken of the fabric covering of the annuloplasty ring. Once the thread has loosely coupled the annuloplasty ring to the mitral valve annulus tissue, the annuloplasty ring is slid into contact with the mitral annulus. The tissue of the posterior mitral annulus that was previously stretched out, e.g., due to an enlarged heart, is effectively reduced in circumference and pulled forwards towards the anterior mitral leaflet by the tension applied by annuloplasty ring with the suture or thread. As a result, a gap between anterior leaflet 22 and posterior leaflet 24 during ventricular contraction or systole may be reduced and even substantially closed off in many cases thereby significantly reducing or even eliminating mitral insufficiency. After the mitral valve 20 is shaped by the ring, the anterior and posterior leaflets 22, 24 will reform typically by pulling the posterior leaflet 24 forward to properly meet the anterior leaflet 22 and create a new contact line that will enable mitral valve 20 to appear and to function properly.
Although a patient that receives an annuloplasty ring may be subjected to anti-coagulant therapies, the therapies are not extensive, as a patient is only subjected to the therapies for a matter of weeks, e.g., until tissue grows over the annuloplasty ring.
Another type of procedure that is generally effective in reducing mitral valve leakage associated with prolapse of the valve leaflets involves placing a single edge-to-edge suture in the mitral valve 20 that apposes the mid-portions of anterior and posterior leaflets 22, 24. For example, in an Alfieri stitch or a bow-tie repair procedure, an edge-to-edge stitch is made at approximately the center of the gap between an anterior leaflet 22 and a posterior leaflet 24 of a mitral valve 20. Once the stitch is in place between the anterior and posterior leaflets 22, 24, it is pulled in to form a suture which holds anterior leaflet 22 against posterior leaflet 24.
Another surgical procedure that reduces mitral valve leakage involves placing sutures along a mitral valve annulus around the posterior leaflet 24. These sutures may be formed as a double track, e.g., in two “rows” from a single strand of suture material. The sutures are tied off at approximately a central point (P2) of posterior leaflet 24. Pledgets are often positioned under selected sutures to prevent the sutures from tearing through annulus 40. When the sutures are tightened and tied off, the circumference of the annulus 40 may effectively be reduced to a desired size such that the size of a systolic gap between posterior leaflet 24 and an anterior leaflet 22 may be reduced.
While invasive surgical procedures have proven to be effective in the treatment of mitral valve leakage, invasive surgical procedures often have significant drawbacks. Any time a patient undergoes open-heart surgery, there is a risk of infection. Opening the sternum and using a cardiopulmonary bypass machine has also been shown to result in a significant incidence of both short and long term neurological deficits. Further, given the complexity of open-heart surgery, and the significant associated recovery time, people that are not greatly inconvenienced by CHF symptoms, e.g., people at a Class 1 classification, may choose not to have corrective surgery. In addition, people that need open heart surgery the most, e.g., people at a Class 4 classification, may either be too frail or too weak to undergo the surgery. Hence, many people that may benefit from a surgically repaired mitral valve may not undergo surgery.
In another method, a cinching device is placed within the coronary sinus (CS) using a catheter system, with distal, mid, and proximal anchors within the lumen of the CS to allow plication of the annulus 40 via the CS. In practice, these anchors are cinched together and the distance between them is shortened by pulling a flexible tensile member such as a cable or suture with the intent being to shorten the valve annulus 40 and pull the posterior leaflet 24 closer to the anterior leaflet 22 in a manner similar to an annuloplasty procedure. Unfortunately, since the tissue that forms the CS is relatively delicate, the anchors are prone to tear the tissue during the cinching procedure. In addition, the effect on the mitral annulus may be reduced when the CS of a particular patient is not directly aligned with the mitral annulus. Other minimally invasive techniques have been proposed but have various drawbacks related to such factors as effectiveness and/or accuracy of catheter-based implementation.
In one embodiment, a system is provided for accurately introducing an element into tissue proximate (i.e., either at or close to) the mitral valve annulus of the heart of a patient. The element may be any desired structure suitable for the intended purpose. In one more specific embodiment, for example, the element may advantageously comprise a guide wire. The system includes a first catheter device having a first distal end portion capable of being introduced through the vascular system of the patient and into the coronary sinus proximate the mitral valve annulus. The first catheter device includes first, second and third spaced apart radiopaque markers at the first distal end portion. The system further includes a second catheter device having a second distal end portion capable of being introduced through the vascular system of the patient and into the left ventricle of the heart proximate the mitral valve annulus. The second catheter device includes a fourth radiopaque marker at the second distal end portion and a lumen for delivering an element from the second distal end portion. The fourth radiopaque marker may be aligned with reference to at least one of the first, second or third radiopaque markers to deliver the element into the mitral valve tissue. In one exemplary embodiment, for example, the fourth radiopaque marker is aligned with the first radiopaque marker of the first catheter device generally at location P2 of the posterior mitral annulus. The first, second and third radiopaque markers may be spaced apart to correspond to locations P1, P2 and P3 of the posterior mitral valve annulus.
A method is also provided for accurately introducing an element into tissue proximate the mitral valve annulus using a first catheter device having a first distal end portion with a first radiopaque marker and a second catheter device having a second distal end portion with a lumen. The method comprises introducing the first distal end portion of the first catheter device through the vascular system of the patient and into the coronary sinus proximate the mitral valve annulus. The first radiopaque marker is positioned at a desired location in the coronary sinus proximate the mitral valve annulus. The second distal end portion of the second catheter device is introduced through the vascular system of the patient and into the heart proximate the mitral valve annulus. The second distal end portion is positioned in a desired orientation relative to the first radiopaque marker. The element is then delivered through the lumen into tissue proximate the mitral valve annulus with the second distal end portion in the desired orientation.
The method of accurately introducing the element into tissue proximate the mitral valve annulus may further comprise delivering a first guide wire through the mitral valve annulus and into the left atrium of the heart from the left ventricle of the heart. The method may further comprise guiding a second element over the first guide wire to a position proximate the mitral valve annulus and the second element may further comprise a third catheter device. A second guide wire may be delivered from the third catheter device through the mitral valve annulus and into the left atrium of the heart from the left ventricle of the heart. The method may further comprise using the first and second guide wires to deliver first and second anchors, respectively, into the mitral valve annulus, shortening the distance between the first and second anchors, and locking the first and second anchors with respect to each other. This may, for example, form plicated annulus tissue helpful for reducing regurgitation through the mitral valve. A third guide wire may be delivered from the third catheter device through the mitral valve annulus and into the left atrium of the heart from the left ventricle of the heart. This third guide wire may be used to deliver a third anchor into the mitral valve annulus and the distance between at least two of the first, second or third anchors may be shortened and then at least these two anchors may be locked with respect to each other. In an illustrative embodiment, all three anchors are locked with respect to each other with the tissue plicated between each of the adjacent anchors. The first distal end portion may further comprise two additional radiopaque markers spaced apart on opposite sides of the first radiopaque marker. In this case, the method may further comprise positioning the first radiopaque marker at a location in the coronary sinus proximate location P2 of the mitral valve annulus, and positioning the two additional radiopaque markers in the coronary sinus respectively more proximate to locations P1 and P3 of the mitral valve annulus. As further options, the second distal end portion may further include a second radiopaque marker and positioning the second distal end may further comprise positioning the second radiopaque marker in a desired orientation relative to the first radiopaque marker. The first radiopaque marker may have a predetermined cross sectional shape (e.g., circular) when viewed directly along the longitudinal axis of the first catheter device. In association with this feature, the method may further comprise viewing the first radiopaque marker directly along the longitudinal axis of the first catheter device while positioning the second distal end portion in the desired orientation.
In another illustrative embodiment, a catheter device is provided and capable of being directed through the vascular system of a patient and delivering first and second elements into tissue. Again, these elements may be any structure suited for the intended purpose. The catheter device comprises first, second and third catheter members respectively including first, second and third lumens. A first connecting member is coupled between the first and second catheter members and a second connecting member coupled between the first and third catheter members. The second and third catheter members are laterally movable in generally opposite directions relative to the first catheter member between collapsed positions suitable for delivery of the first, second and third catheter members through the vascular system and expanded positions in which the second and third catheter members are at laterally spaced apart positions relative to the first catheter member for delivering the first and second elements into the tissue through the second and third lumens.
The catheter device may further comprise a third connecting member coupled between the first and second catheter members and a fourth connecting member coupled between the first and third catheter members. The first, second, third and fourth connecting members may further comprise bars pivotally coupled between the first, second and third catheter members. The device may further comprise an outer catheter member or sheath having a fourth lumen with the fourth lumen receiving the first, second and third catheter members. In this embodiment, the first, second and third catheter members may therefore be a triple lumen catheter received within and extendable from the distal end of an outer sheath. The second and third catheter members may be movable in a lengthwise direction relative to the first catheter member as the second and third catheter members move laterally to the expanded positions.
The catheter device including the triple lumen catheter, or first, second and third catheter members, may further comprise first, second and third guide wires respectively received in the first, second and third lumens. For example, the first guide wire may be used as an initial guide for delivery of the catheter device to a surgical site, such as within the left ventricle of the heart, and the second and third guide wires may be extendable from the device into tissue, such as mitral valve annulus tissue. The first, second and third guide wires may further comprise radiofrequency (RF) energy delivery wires capable of applying radiofrequency energy to assist with penetrating the tissue.
In another embodiment, a method is provided for delivering respective elements into spaced apart locations along an annulus of a mitral valve using a catheter device including first, second and third catheter members that respectively include first, second and third lumens. The method comprises directing a first guide wire through the vascular system and into the heart of a patient. The first, second and third catheter members are introduced through the vascular system and into the heart of the patient with the first guide wire received in the first lumen and with the first, second and third catheter members are in a collapsed state relative to one another. Distal end portions of the first, second and third catheter members are positioned proximate the annulus. The distal end portions of the second and third catheter members are expanded laterally away from the first catheter member. The respective elements are then delivered respectively into tissue proximate the annulus through the second and third lumens.
The method of delivering respective elements into spaced apart locations along the annulus may further comprise delivering second and third guide wires respectively through the second and third lumens. The method may further comprise applying radiofrequency energy with distal tip portions of the second and third guide wires to assist with penetrating through the tissue. The distal end portions of the first, second and third guide wires may be extended into the left atrium of the heart. The method may then further comprise delivering first, second and third anchors into the tissue using the first, second and third guide wires as guides to the spaced apart locations. The first, second and third anchors may be connected to the tissue. Distances between two or more of the anchors may be shortened and locked in position as generally described above. Respective first, second and third flexible tensile member portions may be coupled to the first, second and third anchors and locking the first, second and third anchors may further comprise locking at least two of the first, second or third flexible tensile member portions together. The flexible tensile member portions may be comprised of any suitable material having requisite strength, flexibility and biocompatibility. For this purpose, for example, any suitable suture material, which may be portions of the same suture material, or discrete and separate suture threads having respective free ends, may be used. The first, second and third anchors may be respectively secured to the first, second and third flexible tensile members to form first, second and third anchor assemblies. These anchor assemblies may be delivered to the spaced apart locations via at least one anchor delivery catheter. In an illustrative embodiment, these anchor assemblies are individually delivered to the left ventricle via individual, separate anchor delivery catheters.
In another embodiment, a tissue anchor is provided generally comprising a flexible tensile member and a plurality of discrete, flat flexible anchor elements coupled for movement along the flexible tensile member to form one illustrative embodiment of an anchor assembly. The flexible tensile member and at least one of the plurality of discrete, flat flexible anchor elements are capable of being inserted through tissue and of moving between an elongate configuration and a shortened configuration suitable for anchoring the assembly against at least one side of the tissue. This anchor assembly includes a proximal end portion, a distal end portion, and a compressible intermediate portion between the proximal and distal end portions. The compressible intermediate portion is compressible in that it may be shortened during an anchoring process. For example, it may comprise multiple anchor elements itself, or more simply a space between proximal and distal anchor elements connected by the flexible tensile member. The anchor elements can slide relative to the flexible tensile member and the flexible tensile member is capable of being pulled to cause the anchor elements to move relative to the flexible tensile member from the elongate configuration to the shortened configuration.
In this anchor assembly embodiment, the anchor elements may be formed from any suitable biocompatible material. For example, the material may be selected from at least one of natural fibers, synthetic fibers, polymers, metals or any combinations thereof (i.e., combinations with one another and/or with other materials). In one embodiment, the anchor elements are formed of material that promotes tissue ingrowth such that after implantation, the anchor assembly will be essentially covered by natural tissue of the patient. The flexible tensile member may comprise a suture having a suitable lock member, such as a simple slip knot for allowing the proximal end of the flexible tensile member to be pulled causing movement of the slip knot distally and resulting in compression or relative movement of two or more anchor elements toward each other. The flexible tensile member may extend through each of the anchor elements at multiple locations and one or more of the anchor elements and/or the flexible tensile member, or both, may have at least one radiopaque marker to allow visualization under a suitable viewing device such as a fluoroscope during and/or after the anchor installation procedure. In this embodiment the plurality of discrete, flat flexible anchor elements may have any suitable shape. The anchor elements are sufficiently flexible to allow contraction or folding into an anchor delivery catheter and subsequent expansion or unfolding after deployment from the anchor delivery catheter to provide a wider retaining surface against the tissue. A deploying device may be operatively associated with the anchor delivery catheter and operable to extend or deploy the anchor assembly from the anchor delivery catheter. For example, this deploying device may further comprise a deploying member, such as a flexible rod or inner deployment catheter, capable of pushing the anchor assembly at least partially out of the lumen of the anchor delivery catheter.
In another embodiment, a method is provided for anchoring tissue with a first anchor assembly comprised of a first plurality of discrete, flat flexible anchor elements. The first anchor assembly includes a proximal end portion, a distal end portion and a compressible intermediate portion located between the proximal and distal end portions and movable between an elongated configuration and a shortened configuration. The method comprises inserting at least one of the anchor elements through the tissue and pulling a first flexible tensile member coupled for sliding movement relative to the first plurality of discrete, flat flexible anchor elements. This draws the proximal and distal end portions of the first anchor assembly toward each other and compresses the intermediate portion into the shortened configuration with the assembly engaged against the tissue. The tissue may comprise the mitral valve annulus and the first anchor assembly may be engaged on opposite sides of the tissue, such as on opposite sides of the mitral valve annulus. The method may further comprise inserting second and even third anchor assemblies through the tissue at spaced apart locations from the first anchor assembly and drawing the two or three anchor assemblies toward each other to plicate the tissue whereupon the anchor assemblies are locked relative to each other to lock the plicated condition of the tissue. This procedure may, for example, be repeated any number of times to plicate the posterior portion of the mitral valve annulus for purposes of achieving annuloplasty.
In another embodiment, a suture cutter is provided for percutaneously cutting a suture located within a patient. The suture cutter may comprise an actuator for manipulation by a medical professional and an intermediate catheter portion operatively coupled to the actuator for insertion into the vascular system of the patient. A cutting assembly is operatively coupled to the intermediate catheter portion and the actuator. The cutting assembly includes a blade housing and a blade with a cutting edge mounted for movement in the blade housing. An adjustably sized cutting window is defined between the cutting edge and the blade housing and the cutting edge cuts a suture received inside of the cutting window as the cutting edge moves in the blade housing to reduce the size of the cutting window. In one embodiment, an anvil may be positioned on an opposite side of the cutting window from the cutting edge and the suture may be cut against the anvil. In another embodiment, a blade receiving slot may be located on an opposite side of the cutting window from the cutting edge and the suture may be cut as the blade moves into the blade receiving slot. The blade housing may further comprise a first aperture on one side of the blade and a second aperture on an opposite side of the blade such that the suture is adapted to pass from the first aperture to the second aperture through the cutting window.
In another embodiment, a method of cutting a suture located within a patient is provided and involves positioning a suture cutter within the patient, with the suture cutter including a blade movable through an adjustably sized cutting window. A suture is directed through the cutting window, such as at a time before the suture cutter is directed into the patient through the vascular system. The size of the cutting window is reduced by moving the blade towards the suture and the suture is then cut with the blade, either against an anvil or by directing the blade into a blade receiving space past the suture (e.g., into a slot). The suture cutter may be directed through a catheter leading into the vascular system of the patient. The suture cutter may be used, for example, to cut the tails from the sutures used during one or more of the annuloplasty procedures described herein.
In another embodiment, a plication assistance device is provided and may be used, for example, to tension and lock the flexible tensile members described herein. The device comprises a support structure and a first carriage fixed to the support structure and configured to hold an outer plication catheter. A second carriage is fixed to the support structure at a location proximal to the first carriage. At least one of the first or second carriages is slidable along the support structure and capable of being locked in position relative to the support structure. The second or proximal carriage is configured to hold an inner plication catheter. A first suture tensioning mechanism is mounted to the support structure at a location proximal to the second carriage and a second suture tensioning mechanism is mounted to the support structure also at a location proximal to the second carriage. The plication assistance device may further comprise a third suture tensioning mechanism mounted to the support structure at a location proximal to the second carriage. The first and second suture tensioning mechanisms may further comprise first and second rotatable spools. The first and second carriages may respectively include first and second locking devices for securing the outer plication catheter and inner plication catheter thereto. The plication assistance device may include a suture tension gauge operatively connected with the support structure and configured to measure tension of a suture being tensioned by at least one of the first or second suture tensioning mechanisms.
Various additional features, advantages, and aspects of the invention will become more readily apparent to those of ordinary skill in the art upon review of the following detailed description of the illustrative embodiments taken in conjunction with the accompanying drawings.
Reference will be made to the various figures in describing the methods, devices and systems in various forms useful to the purpose of plicating tissue, for example, and particularly useful for plicating annulus tissue associated with the mitral valve of a patient. It will be appreciated that although specific details of the methods, devices and systems will be given herein, many different changes, substitutions and additions may be made to such details by those of ordinary skill while still falling within the inventive aspects more generally set forth herein and understood by those of ordinary skill upon review of the present disclosure in its entirety. It should be noted that the terms “proximal” and “distal” are used, as conventional in the art, to denote spatial relationship relative to the person using the particular device or component. That is, “proximal” refers to a position closer to the user and “distal” refers to a position farther from the user.
Referring first to
Referring to
The method then involves the further introduction of respective P1 and P3 guide wires 62, 64 through the use of a triple lumen catheter 70 contained within a sheath 72. Triple lumen catheter 70 and sheath 72 are introduced into the guide catheter 50 after withdrawal of the P2 catheter 52 therefrom. Triple lumen catheter 70 more specifically comprises a central or first catheter member 74 having a lumen 74a threaded over the P2 guide wire 60. In addition to this first or P2 catheter member 74, triple lumen catheter 70 further comprises second and third catheter members 76, 78 respectively corresponding generally to the P1 and P3 locations generally along the posterior mitral annulus 40. The second and third catheter members 76, 78 also include respective lumens 76a, 78a containing respective guide wires 62 and 64. It will be appreciated that other locations along the annulus 40 may be chosen in addition to or instead of those discussed illustratively herein.
As further shown in
Respective connectors 88, 90, 92, 94, 96, 98 couple each connecting bar 80, 82, 84, 86 to the respective catheter members 76, 74, 78 as shown in
Catheter members 76, 78 include lumens 76a, 78a from which the respective P1 and P3 guide wires 62, 64 may be directed as shown in
As shown in
Likewise,
FIGS. 16 and 16A-D generally illustrate a cinching and locking procedure for plicating the mitral annulus tissue 40. Specifically, this can involve the use of an outer plication catheter 130 carrying a suture locker 132 at its distal end. An inner plication catheter 134 is received for sliding movement within the lumen of the outer plication catheter 130. The distal end 134a of the inner plication catheter 134 abuts a proximal portion of the suture locker 132. The suture locker 132 includes a slidable pin 136 having ends that are received in respective slot portions 130a, 130b of outer plication catheter 130 at its distal end. More specifically, the pin 136 is initially retained in an angled slot 130b, and in an identical slot (not shown) on the diametrically opposite side of the outer plication catheter 134, while the catheter assembly 130, 134 is directed through the guide catheter 50 into the left ventricle 14 as shown in
After the respective sutures 106, 116, 126 have been tensioned, the cinching or plicating process and locking process may begin. In this regard, and as shown in
As shown in
The carriages 154, 156 also include respective catheter locks 160, 162 that may be rotated to tighten and loosen the connections between respective catheter hubs 146, 148 and carriages 154, 156. A proximal end portion of the base plate 152 includes suture tensioning mechanisms 164, 166, 168 for the respective sutures 106, 116, 126. More specifically, these mechanisms include spools 170, 172, 174 for receiving proximal end portions of the respective sutures 106, 116, 126 which may be wrapped and firmly engaged with the spools 170, 172, 174. The suture tensioning mechanisms 164, 166, 168 further comprise rotatable knobs 176, 178, 180 connected with respective right angle gear boxes 182, 184, 186 for converting rotation of the knobs 176, 178, 180 to rotation of the spools 170, 172, 174. That is, an output of each gear box 182, 184, 186 is coupled to a respective one of the spools 170, 172, 174. In this manner, each suture 106, 116, 126 may be separately pulled or tensioned by rotating the corresponding knob 176, 178, 180.
In use, the inner and outer plication catheters 130 and 134 are respectively secured and locked into the carriages 154 and 156, as shown in
As best shown in
This suture tension provides potential energy that moves the catheters 130, 134 relative to each other and locks the suture locker 132 as previously described, after the sliding carriage 156 is unlocked by loosening slide lock 158. The plication catheters 130, 132 are then removed from the guide catheter 50 leaving the long proximal tails of the suture 106, 116, 126 extending out of the patient through the guide catheter 50.
A suture cutter 210 is threaded along the sutures 106, 116, 126 through the guide catheter 50 to the position generally shown in
The completed annuloplasty or plication procedure is shown in
While the present invention has been illustrated by a description of various preferred embodiments and while these embodiments have been described in some detail, it is not the intention of the Applicants to restrict or in any way limit the scope of the appended claims to such detail. Additional advantages and modifications will readily appear to those skilled in the art. The various features discussed herein may be used alone or in any combination depending on the needs and preferences of the user. This has been a description of illustrative aspects and embodiments the present invention, along with the preferred methods of practicing the present invention as currently known. However, the invention itself should only be defined by the appended claims.
The present application is a Continuation-In-Part of U.S. Ser. No. 10/949,412, filed on Sep. 24, 2004, now abandoned, which claims the priority of U.S. Provisional Ser. No. 60/554,314, filed on Mar. 18, 2004, and further claims the priority of U.S. Provisional Ser. No. 60/531,855, filed on Dec. 23, 2003.
Number | Name | Date | Kind |
---|---|---|---|
2143910 | Didusch | Jan 1939 | A |
3674014 | Tillander | Jul 1972 | A |
3794041 | Frei et al. | Feb 1974 | A |
3841521 | Jarvik | Oct 1974 | A |
3986493 | Hendren, III | Oct 1976 | A |
4042979 | Angell | Aug 1977 | A |
4055861 | Carpentier et al. | Nov 1977 | A |
4258705 | Sorensen et al. | Mar 1981 | A |
4369787 | Lasner et al. | Jan 1983 | A |
4489446 | Reed | Dec 1984 | A |
4532926 | O'Holla | Aug 1985 | A |
4809713 | Grayzel | Mar 1989 | A |
4917698 | Carpentier et al. | Apr 1990 | A |
4945912 | Langberg | Aug 1990 | A |
5016353 | Iten | May 1991 | A |
5041129 | Hayhurst et al. | Aug 1991 | A |
5041130 | Cosgrove et al. | Aug 1991 | A |
5061277 | Carpentier et al. | Oct 1991 | A |
5104407 | Lam et al. | Apr 1992 | A |
5123914 | Cope | Jun 1992 | A |
5171232 | Castillo et al. | Dec 1992 | A |
5192302 | Kensey et al. | Mar 1993 | A |
5201880 | Wright et al. | Apr 1993 | A |
5203777 | Lee | Apr 1993 | A |
5306234 | Johnson | Apr 1994 | A |
5306296 | Wright et al. | Apr 1994 | A |
5337736 | Reddy | Aug 1994 | A |
5360444 | Kusuhara | Nov 1994 | A |
5364393 | Auth et al. | Nov 1994 | A |
5429131 | Scheinman et al. | Jul 1995 | A |
5450860 | O'Connor | Sep 1995 | A |
5452513 | Zinnbauer et al. | Sep 1995 | A |
5464023 | Viera | Nov 1995 | A |
5545178 | Kensey et al. | Aug 1996 | A |
5565122 | Zinnbauer et al. | Oct 1996 | A |
5571215 | Sterman et al. | Nov 1996 | A |
5593424 | Northrup | Jan 1997 | A |
5607471 | Seguin et al. | Mar 1997 | A |
5623943 | Hackett et al. | Apr 1997 | A |
5626590 | Wilk | May 1997 | A |
5640955 | Ockuly et al. | Jun 1997 | A |
5669919 | Sanders et al. | Sep 1997 | A |
5674279 | Wright et al. | Oct 1997 | A |
5682906 | Sterman et al. | Nov 1997 | A |
5690656 | Cope et al. | Nov 1997 | A |
5706827 | Ehr et al. | Jan 1998 | A |
5716367 | Koike et al. | Feb 1998 | A |
5716397 | Myers | Feb 1998 | A |
5716399 | Love | Feb 1998 | A |
5776080 | Thome et al. | Jul 1998 | A |
5776189 | Khalid | Jul 1998 | A |
5797939 | Yoon | Aug 1998 | A |
5813996 | St. Germain et al. | Sep 1998 | A |
5824066 | Gross | Oct 1998 | A |
5827300 | Fleega | Oct 1998 | A |
5829447 | Stevens et al. | Nov 1998 | A |
5830224 | Cohn et al. | Nov 1998 | A |
5851185 | Berns | Dec 1998 | A |
5860920 | McGee et al. | Jan 1999 | A |
5868733 | Ockuly et al. | Feb 1999 | A |
5879366 | Shaw | Mar 1999 | A |
5888240 | Carpentier et al. | Mar 1999 | A |
5906579 | Vander Salm et al. | May 1999 | A |
5911720 | Bourne et al. | Jun 1999 | A |
5928224 | Laufer | Jul 1999 | A |
5931818 | Werp et al. | Aug 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5967984 | Chu et al. | Oct 1999 | A |
5980515 | Tu | Nov 1999 | A |
5984939 | Yoon | Nov 1999 | A |
6015414 | Werp et al. | Jan 2000 | A |
6042581 | Ryan et al. | Mar 2000 | A |
6050472 | Shibata | Apr 2000 | A |
6050936 | Schweich, Jr. et al. | Apr 2000 | A |
6068637 | Popov et al. | May 2000 | A |
6068648 | Cole et al. | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6099460 | Denker | Aug 2000 | A |
6102945 | Campbell | Aug 2000 | A |
6113611 | Allen et al. | Sep 2000 | A |
6126647 | Posey et al. | Oct 2000 | A |
RE36974 | Bonutti | Nov 2000 | E |
6159234 | Bonutti et al. | Dec 2000 | A |
6162168 | Schweich, Jr. et al. | Dec 2000 | A |
6165119 | Schweich, Jr. et al. | Dec 2000 | A |
6165120 | Schweich, Jr. et al. | Dec 2000 | A |
6165183 | Kuehn et al. | Dec 2000 | A |
6173199 | Gabriel | Jan 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6197017 | Brock et al. | Mar 2001 | B1 |
6206895 | Levinson | Mar 2001 | B1 |
6210432 | Solem et al. | Apr 2001 | B1 |
6231587 | Makower | May 2001 | B1 |
6267781 | Tu | Jul 2001 | B1 |
6269819 | Oz et al. | Aug 2001 | B1 |
6285903 | Rosenthal et al. | Sep 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6298257 | Hall et al. | Oct 2001 | B1 |
6306133 | Tu et al. | Oct 2001 | B1 |
6312447 | Grimes | Nov 2001 | B1 |
6319263 | Levinson | Nov 2001 | B1 |
6332089 | Acker et al. | Dec 2001 | B1 |
6332893 | Mortier et al. | Dec 2001 | B1 |
6352543 | Cole | Mar 2002 | B1 |
6385472 | Hall et al. | May 2002 | B1 |
6401720 | Stevens et al. | Jun 2002 | B1 |
6402680 | Mortier et al. | Jun 2002 | B2 |
6402781 | Langberg et al. | Jun 2002 | B1 |
6406420 | McCarthy et al. | Jun 2002 | B1 |
6447522 | Gambale et al. | Sep 2002 | B2 |
6461366 | Seguin | Oct 2002 | B1 |
6500184 | Chan et al. | Dec 2002 | B1 |
6524303 | Garibaldi | Feb 2003 | B1 |
6530952 | Vesely | Mar 2003 | B2 |
6537198 | Vidlund et al. | Mar 2003 | B1 |
6537314 | Langberg et al. | Mar 2003 | B2 |
6542766 | Hall et al. | Apr 2003 | B2 |
6544230 | Flaherty et al. | Apr 2003 | B1 |
6554852 | Oberlander | Apr 2003 | B1 |
6562019 | Sell | May 2003 | B1 |
6565562 | Shah et al. | May 2003 | B1 |
6589208 | Ewers et al. | Jul 2003 | B2 |
6594517 | Nevo | Jul 2003 | B1 |
6596014 | Levinson et al. | Jul 2003 | B2 |
6619291 | Hlavka et al. | Sep 2003 | B2 |
6626919 | Swanstrom | Sep 2003 | B1 |
6626930 | Allen et al. | Sep 2003 | B1 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6629921 | Schweich, Jr. et al. | Oct 2003 | B1 |
6655386 | Makower et al. | Dec 2003 | B1 |
6656221 | Taylor et al. | Dec 2003 | B2 |
6669687 | Saadat | Dec 2003 | B1 |
6669707 | Swanstrom et al. | Dec 2003 | B1 |
6676702 | Mathis | Jan 2004 | B2 |
6689164 | Sequin | Feb 2004 | B1 |
6699263 | Cope | Mar 2004 | B2 |
6702825 | Frazier et al. | Mar 2004 | B2 |
6702826 | Liddicoat et al. | Mar 2004 | B2 |
6718985 | Hlavka et al. | Apr 2004 | B2 |
6723038 | Schroeder et al. | Apr 2004 | B1 |
6730112 | Levinson | May 2004 | B2 |
6733509 | Nobles et al. | May 2004 | B2 |
6736808 | Motamedi et al. | May 2004 | B1 |
6746472 | Frazier et al. | Jun 2004 | B2 |
6764500 | Muijs Van De Moer et al. | Jul 2004 | B1 |
6769434 | Liddicoat et al. | Aug 2004 | B2 |
6793618 | Schweich, Jr. et al. | Sep 2004 | B2 |
6866673 | Oren et al. | Mar 2005 | B2 |
6913608 | Liddicoat et al. | Jul 2005 | B2 |
6921407 | Nguyen et al. | Jul 2005 | B2 |
6923823 | Bartlett et al. | Aug 2005 | B1 |
6942694 | Liddicoat et al. | Sep 2005 | B2 |
6945978 | Hyde | Sep 2005 | B1 |
6949122 | Adams et al. | Sep 2005 | B2 |
6964674 | Matsuura et al. | Nov 2005 | B1 |
6964683 | Kowalsky et al. | Nov 2005 | B2 |
7004958 | Adams et al. | Feb 2006 | B2 |
7037334 | Hlavka et al. | May 2006 | B1 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7166127 | Spence et al. | Jan 2007 | B2 |
7211094 | Gannoe et al. | May 2007 | B2 |
20010005787 | Oz et al. | Jun 2001 | A1 |
20010039436 | Frazier et al. | Nov 2001 | A1 |
20010049492 | Frazier et al. | Dec 2001 | A1 |
20020013571 | Goldfarb et al. | Jan 2002 | A1 |
20020016628 | Langberg et al. | Feb 2002 | A1 |
20020026198 | Ockuly et al. | Feb 2002 | A1 |
20020026216 | Grimes | Feb 2002 | A1 |
20020029080 | Mortier et al. | Mar 2002 | A1 |
20020042621 | Liddicoat et al. | Apr 2002 | A1 |
20020072758 | Reo et al. | Jun 2002 | A1 |
20020087169 | Brock et al. | Jul 2002 | A1 |
20020087173 | Alferness et al. | Jul 2002 | A1 |
20020087178 | Nobles et al. | Jul 2002 | A1 |
20020095167 | Liddicoat et al. | Jul 2002 | A1 |
20020100485 | Stevens et al. | Aug 2002 | A1 |
20020103532 | Langberg et al. | Aug 2002 | A1 |
20020107531 | Schreck et al. | Aug 2002 | A1 |
20020128708 | Northrup, III et al. | Sep 2002 | A1 |
20020143383 | Parodi | Oct 2002 | A1 |
20020156526 | Hlavka et al. | Oct 2002 | A1 |
20020165535 | Lesh et al. | Nov 2002 | A1 |
20020169359 | McCarthy et al. | Nov 2002 | A1 |
20020169502 | Mathis | Nov 2002 | A1 |
20020169504 | Alferness et al. | Nov 2002 | A1 |
20020173841 | Ortiz et al. | Nov 2002 | A1 |
20020183766 | Seguin | Dec 2002 | A1 |
20020183836 | Liddicoat et al. | Dec 2002 | A1 |
20020183837 | Streeter et al. | Dec 2002 | A1 |
20020183838 | Liddicoat et al. | Dec 2002 | A1 |
20020183841 | Cohn et al. | Dec 2002 | A1 |
20020188170 | Santamore et al. | Dec 2002 | A1 |
20030018358 | Saadat | Jan 2003 | A1 |
20030069593 | Tremulis et al. | Apr 2003 | A1 |
20030069636 | Solem et al. | Apr 2003 | A1 |
20030078465 | Pai et al. | Apr 2003 | A1 |
20030078654 | Taylor et al. | Apr 2003 | A1 |
20030078671 | Lesniak et al. | Apr 2003 | A1 |
20030083538 | Adams et al. | May 2003 | A1 |
20030105474 | Bonutti | Jun 2003 | A1 |
20030105520 | Alferness et al. | Jun 2003 | A1 |
20030120340 | Liska et al. | Jun 2003 | A1 |
20030130730 | Cohn et al. | Jul 2003 | A1 |
20030144697 | Mathis et al. | Jul 2003 | A1 |
20030160721 | Gilboa et al. | Aug 2003 | A1 |
20030171776 | Adams et al. | Sep 2003 | A1 |
20030171806 | Mathis et al. | Sep 2003 | A1 |
20030199974 | Lee et al. | Oct 2003 | A1 |
20030208195 | Thompson et al. | Nov 2003 | A1 |
20030212453 | Mathis et al. | Nov 2003 | A1 |
20030220685 | Hlavka et al. | Nov 2003 | A1 |
20030233142 | Morales et al. | Dec 2003 | A1 |
20040003819 | St. Goar et al. | Jan 2004 | A1 |
20040019378 | Hlavka et al. | Jan 2004 | A1 |
20040024414 | Downing | Feb 2004 | A1 |
20040030382 | St. Goar et al. | Feb 2004 | A1 |
20040039442 | St. Goar et al. | Feb 2004 | A1 |
20040044364 | DeVries et al. | Mar 2004 | A1 |
20040049211 | Tremulis et al. | Mar 2004 | A1 |
20040092962 | Thornton et al. | May 2004 | A1 |
20040093023 | Allen et al. | May 2004 | A1 |
20040122456 | Saadat et al. | Jun 2004 | A1 |
20040127983 | Mortier et al. | Jul 2004 | A1 |
20040133063 | McCarthy et al. | Jul 2004 | A1 |
20040147958 | Lam et al. | Jul 2004 | A1 |
20040152947 | Schroeder et al. | Aug 2004 | A1 |
20040162568 | Saadat et al. | Aug 2004 | A1 |
20040167539 | Kuehn et al. | Aug 2004 | A1 |
20040167620 | Ortiz et al. | Aug 2004 | A1 |
20040172046 | Hlavka et al. | Sep 2004 | A1 |
20040186486 | Roue et al. | Sep 2004 | A1 |
20040186566 | Hindichs et al. | Sep 2004 | A1 |
20040193191 | Starksen et al. | Sep 2004 | A1 |
20040220473 | Lualdi | Nov 2004 | A1 |
20040236419 | Milo | Nov 2004 | A1 |
20040243153 | Liddicoat et al. | Dec 2004 | A1 |
20040243227 | Starksen et al. | Dec 2004 | A1 |
20040260317 | Bloom et al. | Dec 2004 | A1 |
20050033446 | Deem et al. | Feb 2005 | A1 |
20050049681 | Greenhalgh et al. | Mar 2005 | A1 |
20050055087 | Starksen | Mar 2005 | A1 |
20050055089 | Macoviak et al. | Mar 2005 | A1 |
20050065550 | Starksen et al. | Mar 2005 | A1 |
20050065601 | Lee et al. | Mar 2005 | A1 |
20050075723 | Schroeder et al. | Apr 2005 | A1 |
20050107810 | Morales et al. | May 2005 | A1 |
20050107812 | Starksen et al. | May 2005 | A1 |
20050107871 | Realyvasquez et al. | May 2005 | A1 |
20050119523 | Starksen et al. | Jun 2005 | A1 |
20050119734 | Spence et al. | Jun 2005 | A1 |
20050119735 | Spence et al. | Jun 2005 | A1 |
20050125011 | Spence | Jun 2005 | A1 |
20050131438 | Cohn | Jun 2005 | A1 |
20050143811 | Realyvasquez | Jun 2005 | A1 |
20050148815 | Mortier et al. | Jul 2005 | A1 |
20050149014 | Hauck et al. | Jul 2005 | A1 |
20050159810 | Filsoufi | Jul 2005 | A1 |
20050177228 | Solem et al. | Aug 2005 | A1 |
20050184122 | Hlavka et al. | Aug 2005 | A1 |
20050216039 | Lederman | Sep 2005 | A1 |
20050251157 | Saadat et al. | Nov 2005 | A1 |
20050251159 | Ewers et al. | Nov 2005 | A1 |
20050251202 | Ewers et al. | Nov 2005 | A1 |
20050251205 | Ewers et al. | Nov 2005 | A1 |
20050251206 | Maahs et al. | Nov 2005 | A1 |
20050251207 | Flores et al. | Nov 2005 | A1 |
20050251208 | Elmer et al. | Nov 2005 | A1 |
20050251209 | Saadat et al. | Nov 2005 | A1 |
20050251210 | Westra et al. | Nov 2005 | A1 |
20050267571 | Spence et al. | Dec 2005 | A1 |
20060009784 | Behl et al. | Jan 2006 | A1 |
20060069429 | Spence et al. | Mar 2006 | A1 |
20060142756 | Davies et al. | Jun 2006 | A1 |
20060212045 | Schilling et al. | Sep 2006 | A1 |
20070010857 | Sugimoto et al. | Jan 2007 | A1 |
20070080188 | Spence et al. | Apr 2007 | A1 |
20070106310 | Goldin et al. | May 2007 | A1 |
20070112424 | Spence et al. | May 2007 | A1 |
20080228165 | Spence et al. | Sep 2008 | A1 |
20080228198 | Traynor et al. | Sep 2008 | A1 |
20080228265 | Spence et al. | Sep 2008 | A1 |
20080228266 | McNamara et al. | Sep 2008 | A1 |
20080275503 | Spence et al. | Nov 2008 | A1 |
Number | Date | Country |
---|---|---|
1016377 | Jul 2000 | EP |
9604852 | Feb 1996 | WO |
9900059 | Jan 1999 | WO |
0003759 | Jan 2000 | WO |
0044311 | Aug 2000 | WO |
0060995 | Oct 2000 | WO |
0067640 | Nov 2000 | WO |
0200099 | Jan 2002 | WO |
02051329 | Jul 2002 | WO |
02096275 | Dec 2002 | WO |
03001893 | Jan 2003 | WO |
03007796 | Jan 2003 | WO |
03053289 | Jul 2003 | WO |
2004045378 | Jun 2004 | WO |
2004112658 | Dec 2004 | WO |
2005011463 | Feb 2005 | WO |
2005013832 | Feb 2005 | WO |
2005025644 | Mar 2005 | WO |
2006064490 | Jun 2006 | WO |
2007005394 | Jan 2007 | WO |
Entry |
---|
U.S. Patent and Trademark Office, International Search Report and Written Opinion in PCT Application No. PCT/US2008/056620, Oct. 15, 2008. |
U.S. Patent and Trademark Office, International Search Report and Written Opinion in PCT Application No. PCT/US2008/080735, Dec. 17, 2008. |
U.S. Patent and Trademark Office, Office Action in U.S. Appl. No. 10/949,133, Dec. 10, 2008. |
U.S. Patent and Trademark Office, Office Action in U.S. Appl. No. 10/948,923, Mar. 18, 2008. |
Cardiac Surgery Renaissance, Anatomical Landscape; Composite Profile of CABG and Valve Procedures, Apr. 25, 1996, Cardiology Roundtable Interviews. |
F. Maisano et al., The Double-Orifice Technique as a Standardized Approach to Treat Mitral Regurgitation Due to Severe Myxomatous Disease: Surgical Technique, European Journal of Cardio-thoracis Surgery, 1998. |
Douglas P. Zipes, MD et al., Ablation of Free Wall Accessory Pathways, Catheter Ablation of Arrhythmias, Chapter 8, 7 pgs., 1994. |
Gsolt L. Nagy et al., Mitral Annuloplasty with a Suture Technique, European Journal of Cardio-thoracic Surgery 18, Aug. 15, 2000, 1 pg. |
David L.S. Morales et al., Development of an Off Bypass Mitral Valve Repair, Department of Surgery, Columbia University, College of Physicians and Surgeons, New York, NY. |
http://www.hsforum.com/vol2/issue2/1999-4963 tables.html. |
http:/www.hsforum.com/vol2/issue2/1999-4963figures.html. |
http://medtronic.com/cardiac/heartvalves/duran—band/. |
European Patent Office, Supplementary Search Report in EP Application No. 02764186.9, Jan. 26, 2007. |
European Patent Office, Supplementary Search Report in EP Application No. 02733960.5, Jan. 25, 2007. |
European Patent Office, International Search Report and Written Opinion in PCT Application Serial No. PCT/US2006/024897, Dec. 6, 2006. |
U.S. Patent and Trademark Office, Office Action in U.S. Appl. No. 10/948,922, Sep. 11, 2007. |
U.S. Patent and Trademark Office, Office Action in U.S. Appl. No. 11/111,044, Jul. 16, 2007. |
U.S. Patent and Trademark Office, Office Action in U.S. Appl. No. 10/622,207, May 21, 2007. |
U.S. Patent and Trademark Office, Office Action in U.S. Appl. No. 10/622,207, Jul. 14, 2006. |
U.S. Patent and Trademark Office, Office Action in U.S. Appl. No. 10/622,207, Aug. 23, 2005. |
U.S. Patent and Trademark Office, Office Action in U.S. Appl. No. 10/622,207, Dec. 28, 2004. |
European Patent Office, European Examination Report in Application Serial No. 02764186.9, Feb. 11, 2008. |
U.S. Patent and Trademark Office, Office Action in U.S. Appl. No. 11/111,044, Feb. 26, 2008. |
U.S. Patent and Trademark Office, Office Action in U.S. Appl. No. 10/949,412, Aug. 6, 2008. |
U.S. Patent and Trademark Office, Office Action in U.S. Appl. No. 10/689,872, Aug. 8, 2008. |
U.S. Patent and Trademark Office, Office Action in U.S. Appl. No. 10/622,207, Apr. 11, 2008. |
Number | Date | Country | |
---|---|---|---|
20080228267 A1 | Sep 2008 | US |
Number | Date | Country | |
---|---|---|---|
60554314 | Mar 2004 | US | |
60531855 | Dec 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10949412 | Sep 2004 | US |
Child | 11685242 | US |